Essen, Germany – Cost-cutting and restructuring efforts at Evonik appear to be taking effect, with the company reporting a 24.7% increase in adjusted EBITDA, from 2023’s €1.66bn to €2.06bn in 2024. This was on the back of a slight decline in sales, which fell to €15.16bn from €15.27 in 2023.
In its specialty additives division, which includes PU additives, sales were up by 2.8%, rising to €3.6m, and adjusted EBITDA up 11% to €744m. Volumes were considerably higher, the company said, offset by selling prices that were down after lower raw material costs were passed on to customers. However, sales of additives for PU foams and consumer durables were down slightly because of a small downward trend in selling prices.
It also said that its Next Generation Solutions products with proven sustainability advantages, including biobased and circular economy products, now account for 45% of its sales. This is up from 43% in 2023.